Abstract
Congenital myopathies (CM) are a gamut of clinicopathologically and genetically distinct disorders characterized by early-onset hypotonia and muscle weakness and inherited in autosomal dominant, recessive, or X-linked manner. Sometimes sporadic forms are seen. Respiratory muscle weakness is often severe and out of proportion to that of limb muscle weakness. Serum CK levels are usually within normal limits. The pathological abnormality common to most of the CM is the presence of hypotrophic type 1 fibers expressing slow myosin, which may sometimes be the only abnormality. Additional pathological features may include cytoplasmic bodies, nemaline rods, cores, tubular aggregates, central nuclei, caps, etc. Muscle biopsies can also show more than one of the aforementioned findings. There is a very high rate of phenotypic variability and genetic heterogeneity with respect to congenital myopathies [1]. Myocyte necrosis and endomysial fibrosis are rare features and when present prompt alternative diagnosis. The categories of CM are broad and encompass several entities, and discussing each detailed is beyond the scope of this chapter. Only the common CM are discussed, and the readers are requested to refer dedicated papers on individual CM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sewry CA, Wallgren-Pettersson C. Myopathology in congenital myopathies. Neuropathol Appl Neurobiol. 2017;43:5–23.
Shy GM, Engel WK, Somers JE, et al. Nemaline myopathy. A new congenital myopathy. Brain. 1963;86:793–810.
Maggi L, Scoto M, Cirak S, et al. Congenital myopathies—clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord. 2013;23:195–205.
Wallgren-Pettersson C, Sewry CA, Nowak KJ, et al. Nemaline myopathies. Semin Pediatr Neurol. 2011;18:230–8.
Wallgren-Pettersson C, Lehtokari VL, Kalimo H, et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain. 2007;130:1465–76.
Wallgren-Pettersson C, Pelin K, Hilpela P, et al. Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy. Neuromuscul Disord. 1999;9:564–72.
Malfatti E, Romero NB. Nemaline myopathies: state of the art. Rev Neurol (Paris). 2016;172:614–9.
Malfatti E, Lehtokari VL, Bohm J, et al. Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun. 2014;2:44.
Romero NB, Lehtokari VL, Quijano-Roy S, et al. Core-rod myopathy caused by mutations in the nebulin gene. Neurology. 2009;73:1159–61.
Jain RK, Jayawant S, Squier W, et al. Nemaline myopathy with stiffness and hypertonia associated with an ACTA1 mutation. Neurology. 2012;78:1100–3.
Finsterer J, Stollberger C. Review of cardiac disease in nemaline myopathy. Pediatr Neurol. 2015;53:473–7.
Sewry CA, Holton JL, Dick DJ, et al. Zebra body myopathy is caused by a mutation in the skeletal muscle actin gene (ACTA1). Neuromuscul Disord. 2015;25:388–91.
Gupta VA, Ravenscroft G, Shaheen R, et al. Identification of KLHL41 mutations implicates BTB-Kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy. Am J Hum Genet. 2013;93:1108–17.
Yuen M, Sandaradura SA, Dowling JJ, et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. J Clin Investig. 2014;124:4693–708.
Malfatti E, Bohm J, Lacene E, et al. A premature stop codon in MYO18B is associated with severe nemaline myopathy with cardiomyopathy. J Neuromuscul Dis. 2015;2:219–27.
Alazami AM, Kentab AY, Faqeih E, et al. A novel syndrome of Klippel-Feil anomaly, myopathy, and characteristic facies is linked to a null mutation in MYO18B. J Med Genet. 2015;52:400–4.
Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology. 2017;128(1):168–80.
Dowling JJ, Lillis S, Amburgey K, et al. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2011;21:420–7.
Quinlivan R, Jungbluth H. Myopathic causes of exercise intolerance with rhabdomyolysis. Dev Med Child Neurol. 2012;54:886–91.
Voermans NC, Snoeck M, Jungbluth H. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction. Rev Neurol (Paris). 2016;172:546–58.
Loseth S, Voermans NC, Torbergsen T, et al. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol. 2013;260:1504–10.
Sewry CA, Muller C, Davis M, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12:930–8.
Wilmshurst JM, Lillis S, Zhou H, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol. 2010;68:717–26.
Jungbluth H, Zhou H, Sewry CA, et al. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2007;17:338–45.
Monnier N, Romero NB, Lerale J, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet. 2000;9:2599–608.
Jungbluth H, Sewry CA, Buj-Bello A, et al. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. Neuromuscul Disord. 2003;13:55–9.
Dahl N, Hu LJ, Chery M, et al. Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region. Am J Hum Genet. 1995;56:1108–15.
Tanner SM, Orstavik KH, Kristiansen M, et al. Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother. Hum Genet. 1999;104:249–53.
Savarese M, Di Fruscio G, Torella A, et al. The genetic basis of undiagnosed muscular dystrophies and myopathies: results from 504 patients. Neurology. 2016;87:71–6.
Longo G, Russo S, Novelli G, et al. Mutation spectrum of the MTM1 gene in XLMTM patients: 10 years of experience in prenatal and postnatal diagnosis. Clin Genet. 2016;89:93–8.
Hedberg C, Lindberg C, Mathe G, et al. Myopathy in a woman and her daughter associated with a novel splice site MTM1 mutation. Neuromuscul Disord. 2012;22:244–51.
Hnia K, Vaccari I, Bolino A, et al. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol Med. 2012;18:317–27.
Al-Qusairi L, Laporte J. T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle. 2011;1:26.
Laporte J, Kress W, Mandel JL. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol. 2001;50:42–6.
Lawlor MW, Beggs AH, Buj-Bello A, et al. Skeletal muscle pathology in X-linked myotubular myopathy: review with cross-species comparisons. J Neuropathol Exp Neurol. 2016;75:102–10.
Romero NB. Centronuclear myopathies: a widening concept. Neuromuscul Disord. 2010;20:223–8.
Liewluck T, Lovell TL, Bite AV, et al. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation. Neuromuscul Disord. 2010;20:801–4.
Agrawal PB, Pierson CR, Joshi M, et al. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am J Hum Genet. 2014;95:218–26.
Sewry CA, Quinlivan RC, Squier W, et al. A rapid immunohistochemical test to distinguish congenital myotonic dystrophy from X-linked myotubular myopathy. Neuromuscul Disord. 2012;22:225–30.
Soussi-Yanicostas N, Chevallay M, Laurent-Winter C, et al. Distinct contractile protein profile in congenital myotonic dystrophy and X-linked myotubular myopathy. Neuromuscul Disord. 1991;1:103–11.
Bitoun M, Maugenre S, Jeannet PY, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37:1207–9.
Bitoun M, Bevilacqua JA, Prudhon B, et al. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol. 2007;62:666–70.
Toussaint A, Cowling BS, Hnia K, et al. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol. 2011;121:253–66.
Carmignac V, Salih MA, Quijano-Roy S, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol. 2007;61:340–51.
Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 2013;81:1205–14.
Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557–67.
Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227–32.
Lamont PJ, Udd B, Mastaglia FL, et al. Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy. J Neurol Neurosurg Psychiatry. 2006;77:208–15.
Cullup T, Lamont PJ, Cirak S, et al. Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement. Neuromuscul Disord. 2012;22:1096–104.
Martinsson T, Oldfors A, Darin N, et al. Autosomal dominant myopathy: missense mutation (Glu-706 --> Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci U S A. 2000;97:14614–9.
Tajsharghi H, Hilton-Jones D, Raheem O, et al. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010;133:1451–9.
Tajsharghi H, Oldfors A. Myosinopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:3–18.
Willis T, Hedberg-Oldfors C, Alhaswani Z, et al. A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness. J Neurol. 2016;263:1427–33.
Fontaine B. Muscle channelopathies and related diseases. Handb Clin Neurol. 2013;113:1433–6.
Cannon SC. Pathomechanisms in channelopathies of skeletal muscle and brain. Annu Rev Neurosci. 2006;29:387–415.
Lehmann-Horn F, Jurkat-Rott K, Rudel R, et al. Diagnostics and therapy of muscle channelopathies—Guidelines of the Ulm Muscle Centre. Acta Myol. 2008;27:98–113.
Raja Rayan DL, Hanna MG. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol. 2010;23:466–76.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gaspar, B.L., Vasishta, R.K., Radotra, B.D. (2019). Congenital Myopathies and Related Diseases. In: Myopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-1462-9_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-1462-9_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1461-2
Online ISBN: 978-981-13-1462-9
eBook Packages: MedicineMedicine (R0)